Christopher Tsu
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in ⓘ
- Aging 2
-
- Protease and Inhibitor Mechanisms 10
- Co-authors
- Lawrence R. Dick (16 shared papers)Charles S. Craik (5 shared papers)John J. Perona (5 shared papers)Olke C. Uhlenbeck (2 shared papers)Paul Hales (8 shared papers)Robert J. Fletterick (3 shared papers)Frank J. Bruzzese (8 shared papers)Paul Fleming (7 shared papers)
- Journals
- Journal of Biological Chemistry (6 papers)Biochemistry (6 papers)Journal of the American Chemical Society (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Molecular Biology (2 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Christopher Tsu
34 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 99
- Hematology 284
- Oncology 584
- Molecular Biology 1.4k
- Cancer Research 211
- Biotechnology 112
Countries citing papers authored by Christopher Tsu
This map shows the geographic impact of Christopher Tsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Tsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Tsu more than expected).
Fields of papers citing papers by Christopher Tsu
This network shows the impact of papers produced by Christopher Tsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Tsu. The network helps show where Christopher Tsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Tsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 409 | |
| 2 | 2010 | 129 | |
| 3 | 2006 | 92 | |
| 4 | 2001 | 80 | |
| 5 | 2011 | 66 | |
| 6 | 1998 | 66 | |
| 7 | 1997 | 64 | |
| 8 | 2000 | 63 | |
| 9 | 2018 | 62 | |
| 10 | 1993 | 61 | |
| 11 | 1993 | 60 | |
| 12 | 2006 | 57 | |
| 13 | 2015 | 48 | |
| 14 | 2013 | 48 | |
| 15 | 2002 | 47 | |
| 16 | 2014 | 46 | |
| 17 | 2008 | 45 | |
| 18 | 2000 | 41 | |
| 19 | 2010 | 39 | |
| 20 | 1997 | 38 |
About Christopher Tsu
Christopher Tsu is a scholar working on Aging, Cancer Research, Biotechnology, Oncology and Hematology, having authored 34 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (16 papers), Peptidase Inhibition and Analysis (13 papers), Protease and Inhibitor Mechanisms (10 papers), Enzyme Production and Characterization (5 papers), Glycosylation and Glycoproteins Research (4 papers), Biochemical and Molecular Research (3 papers), RNA and protein synthesis mechanisms (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Hematology (284 citations), Oncology (584 citations), Molecular Biology (1.4k citations), Cancer Research (211 citations) and Biotechnology (112 citations). Christopher Tsu has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Lawrence R. Dick, Charles S. Craik, John J. Perona, Olke C. Uhlenbeck, Paul Hales, Robert J. Fletterick, Frank J. Bruzzese, Paul Fleming, Jonathan L. Blank and Khristofer Garcia. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, Journal of the American Chemical Society, Bioorganic & Medicinal Chemistry Letters and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.